Gabay, Cem

Title Year Hits Downloads
Nanocrystal-Polymer Particles: Extended Delivery Carriers for Osteoarthritis Treatment 2018 58 22
β Cell-Specific Deletion of the IL-1 Receptor Antagonist Impairs β Cell Proliferation and Insulin Secretion 2018 51 19
Presence of IL-17 in synovial fluid identifies a potential inflammatory osteoarthritic phenotype 2017 72 26
Life-threatening NLRC4-associated hyperinflammation successfully treated with IL-18 inhibition 2017 33 2
Female hormonal factors and the development of anti-citrullinated protein antibodies in women at risk of rheumatoid arthritis 2017 46 4
The prevalence of anticitrullinated protein antibodies increases with age in healthy individuals at risk for rheumatoid arthritis 2017 52 1
The role of female hormonal factors in the development of rheumatoid arthritis 2017 54 0
Rituximab done: what's next in rheumatoid arthritis? A European observational longitudinal study assessing the effectiveness of biologics after rituximab treatment in rheumatoid arthritis 2016 120 0
The Effect of Comedication With a Conventional Synthetic Disease-Modifying Antirheumatic Drug on Drug Retention and Clinical Effectiveness of Anti-Tumor Necrosis Factor Therapy in Patients With Axial Spondyloarthritis 2016 45 0
Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration 2016 31 6
Interleukin-36 potently stimulates human M2 macrophages, Langerhans cells and keratinocytes to produce pro-inflammatory cytokines 2016 33 1
Effectiveness of tocilizumab with and without synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: results from a European collaborative study 2016 96 0
IL-1R1-MyD88 axis elicits papain-induced lung inflammation 2016 26 0
SIK inhibition in human myeloid cells modulates TLR and IL-1R signaling and induces an anti-inflammatory phenotype 2016 69 0
A specific anti-citrullinated protein antibody profile identifies a group of rheumatoid arthritis patients with a toll-like receptor 4-mediated disease 2016 100 27
Distinct expression of interleukin (IL)-36α, β and γ, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn's disease 2016 105 2
Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritis 2016 101 41
Elevated serum levels of free interleukin-18 in adult-onset Still's disease 2016 46 0
Effect of particle size on the biodistribution of nano- and microparticles following intra-articular injection in mice 2016 152 3
IL-36-Induced Toxicity in Neonatal Mice Involves TNF-α Production by Liver Myeloid Cells 2016 65 2
Pneumococcal polysaccharide vaccination in adults undergoing immunosuppressive treatment for inflammatory diseases--a longitudinal study 2015 148 272
Effectiveness of biologic DMARDs in monotherapy versus in combination with synthetic DMARDs in rheumatoid arthritis: data from the Swiss Clinical Quality Management Registry 2015 109 0
Intra-articular bioactivity of a p38 MAPK inhibitor and development of an extended-release system 2015 248 3
The dermatologists' role in managing psoriatic arthritis: results of a Swiss Delphi exercise intended to improve collaboration with rheumatologists 2015 78 0
Limited Contribution of IL-36 versus IL-1 and TNF Pathways in Host Response to Mycobacterial Infection 2015 94 45
Inflammatory Articular Disease in Patients with Inflammatory Bowel Disease: Result of the Swiss IBD Cohort Study 2015 112 0
Atherosclerosis severity is not affected by a deficiency in IL-33/ST2 signaling 2015 132 19
Severe Neutrophil-Dominated Inflammation and Enhanced Myelopoiesis in IL-33-Overexpressing CMV/IL33 Mice 2015 238 2
Adipokines correlate with pain in lower limb osteoarthritis: different associations in hip and knee 2014 170 0
Immune-mediated experimental arthritis in IL-33 deficient mice 2014 217 1
Biological agents in monotherapy for the treatment of rheumatoid arthritis 2014 181 2
Efficacy of intra-articular bevacizumab for relapsing diffuse-type giant cell tumour 2014 221 2
Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics 2014 124 100
In Black Africans with rheumatoid arthritis, ACPA recognize citrullinated fibrinogen and the derived peptides α36-50Cit38,42 and β60-74Cit60,72,74, like in Caucasians 2014 210 1
Joint damage progression in patients with rheumatoid arthritis in clinical remission. Do biologics perform better than synthetic antirheumatic drugs? 2014 113 0
Myeloid-related proteins 8 and 14 contribute to monosodium urate monohydrate crystal-induced inflammation in gout 2014 221 0
Inflammation: IL-36 has proinflammatory effects in skin but not in joints 2014 189 0
The Activity of CCL18 is Principally Mediated through Interaction with Glycosaminoglycans 2013 188 64
Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions 2013 210 134
Endogenous IL-1α is a chromatin-associated protein in mouse macrophages 2013 192 1
Reply to Xie et al. about the article "Distinct serum and synovial fluid interleukin (IL)-33 levels in rheumatoid arthritis, psoriatic arthritis and osteoarthritis" 2013 153 0
The severity of experimental arthritis is independent of IL-36 receptor signaling 2013 206 56
Tocilizumab versus adalimumab for rheumatoid arthritis - Authors' reply 2013 153 0
Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial 2013 172 0
Coexistence of seropositive rheumatoid arthritis and SAPHO syndrome 2013 175 0
Disease severity in K/BxN serum transfer-induced arthritis is not affected by IL-33 deficiency 2013 223 63
Blocking the effects of interleukin-6 in rheumatoid arthritis and other inflammatory rheumatic diseases: systematic literature review and meta-analysis informing a consensus statement 2013 206 82
Hand osteoarthritis: new insights 2013 204 0
Do synovial leptin levels correlate with pain in end stage arthritis? 2013 246 1
Recommendations for the use of ultrasound in rheumatoid arthritis: literature review and SONAR score experience 2013 280 118
Mouse neutrophils express the decoy type 2 interleukin-1 receptor (IL-1R2) constitutively and in acute inflammatory conditions 2013 152 140
EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis 2012 276 418
Mice deficient in hepatocyte-specific IL-1Ra show delayed resolution of concanavalin A-induced hepatitis 2012 160 3
IL-36 signaling amplifies Th1 responses by enhancing proliferation and Th1 polarization of naive CD4+ T cells 2012 241 243
Distinct serum and synovial fluid interleukin (IL)-33 levels in rheumatoid arthritis, psoriatic arthritis and osteoarthritis 2012 247 193
The mouse interleukin (Il)33 gene is expressed in a cell type- and stimulus-dependent manner from two alternative promoters 2012 222 1
Investigation of Caucasian rheumatoid arthritis susceptibility loci in African patients with the same disease 2012 245 114
Evolution of radiographic joint damage in rituximab-treated versus TNF-treated rheumatoid arthritis cases with inadequate response to TNF antagonists 2012 160 208
Differential drug retention between anti-TNF agents and alternative biological agents after inadequate response to an anti-TNF agent in rheumatoid arthritis patients 2012 223 0
Articular inflammation is controlled by myeloid cell-derived interleukin 1 receptor antagonist during the acute phase of arthritis in mice 2012 223 0
Adalimumab in acute sciatica reduces the long-term need for surgery: a 3-year follow-up of a randomised double-blind placebo-controlled trial 2012 257 0
Long-term amelioration of established collagen-induced arthritis achieved with short-term therapy combining anti-CD3 and anti-tumor necrosis factor treatments 2012 145 1
Effectiveness of disease-modifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: results of a 1-year follow-up study from the CERERRA collaboration 2012 202 0
Evaluation of cardiovascular risk in patients with rheumatoid arthritis: do cardiovascular biomarkers offer added predictive ability over established clinical risk scores? 2012 258 1
Spontaneous secretion of interleukin-17 and -22 by human cervical cells in Chlamydia trachomatis infection 2011 215 0
Symptomatic effects of chondroitin 4 and chondroitin 6 sulfate on hand osteoarthritis: a randomized, double-blind, placebo-controlled clinical trial at a single center 2011 208 0
IL-33 biology with potential insights into human diseases 2011 206 0
Autoimmunity and inflammation are independent of class II transactivator type PIV-dependent class II major histocompatibility complex expression in peripheral tissues during collagen-induced arthritis 2011 216 0
Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries 2011 139 0
IL-36R ligands are potent regulators of dendritic and T cells 2011 220 0
The long-term impact of early treatment of rheumatoid arthritis on radiographic progression: a population-based cohort study 2011 208 0
Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipients 2011 498 295
Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center study 2011 292 2
Absence of up-regulation for a proliferation-inducing ligand in Sjögren's sialadenitis lesions 2011 238 0
Distinct roles of hepatocyte- and myeloid cell-derived IL-1 receptor antagonist during endotoxemia and sterile inflammation in mice 2010 141 0
Adalimumab in severe and acute sciatica: a multicenter, randomized, double-blind, placebo-controlled trial 2010 227 0
Polyarthrite rhumatoïde,méthotrexate et fibrose pulmonaire : quelles évidences ? 2010 319 0
IL-1 pathways in inflammation and human diseases 2010 252 0
Anti-apolipoprotein A-1 IgG predicts major cardiovascular events in patients with rheumatoid arthritis 2010 245 1
Influence of anti-infliximab antibodies and residual infliximab concentrations on the occurrence of acquired drug resistance to infliximab in rheumatoid arthritis patients 2010 212 0
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs 2010 212 0
Tocilizumab in a patient with ankylosing spondylitis and Crohn's disease refractory to TNF antagonists 2010 301 0
The effect of alcohol on radiographic progression in rheumatoid arthritis 2010 211 0
Diagnostic value of anti-cyclic citrullinated peptides and association with HLA-DRB1 shared epitope alleles in African rheumatoid arthritis patients 2010 242 314
Enhanced Th1 and Th17 responses and arthritis severity in mice with a deficiency of myeloid cell-specific interleukin-1 receptor antagonist 2010 208 0
Serum lipoproteins attenuate macrophage activation and Toll-Like Receptor stimulation by bacterial lipoproteins 2010 152 326
Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent? 2010 191 0
Anakinra is a possible alternative in the treatment and prevention of acute attacks of pseudogout in end-stage renal failure 2009 140 0
Magnetically retainable microparticles for drug delivery to the joint: efficacy studies in an antigen-induced arthritis model in mice 2009 343 595
The effectiveness of leflunomide as a co-therapy of tumour necrosis factor inhibitors in rheumatoid arthritis: a population-based study 2009 163 7
Synovial tissues concentrate secreted APRIL 2009 217 205
Relationship between gamma-interferon and interleukin-17 in Chlamydia trachomatis reactive arthritis 2009 199 0
Clinical experience with mycophenolate mofetil in systemic autoimmune conditions refractory to common immunosuppressive therapies 2009 241 156
Adaptive immune response in JAM-C-deficient mice: normal initiation but reduced IgG memory 2009 186 2
Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis 2009 218 1
Mutations in the IL1RN locus lead to autoinflammation 2009 202 1
Non-infectious lupus pericarditis: a retrospective hospital-based observation in Yaounde-Cameroon 2009 186 0
Interleukin-33 is biologically active independently of caspase-1 cleavage 2009 151 241
The biological and clinical importance of the 'new generation' cytokines in rheumatic diseases 2009 192 1
Comparison of drug retention rates and causes of drug discontinuation between anti-tumor necrosis factor agents in rheumatoid arthritis 2009 202 0
The proinflammatory cytokine response to Chlamydia trachomatis elementary bodies in human macrophages is partly mediated by a lipoprotein, the macrophage infectivity potentiator, through TLR2/TLR1/TLR6 and CD14 2008 203 0
Impaired counter-regulation of interleukin-1 by the soluble IL-1 receptor type II in patients with chronic liver disease 2008 214 0
IL-1, IL-18, and IL-33 families of cytokines 2008 335 1016
Is tocilizumab a good therapeutic option for RA and systemic-onset juvenile idiopathic arthritis? 2008 209 1
Elevated levels of tumor necrosis factor-alpha in periradicular fat tissue in patients with radiculopathy from herniated disc 2008 225 0
The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33 2008 220 0
At the horizon of innovative therapy in rheumatology: new biologic agents 2008 200 9
Molecular Characterization and Subcellular Localization of Macrophage Infectivity Potentiator, a Chlamydia trachomatis Lipoprotein 2007 242 402
Expression and function of junctional adhesion molecule-C in human and experimental arthritis 2007 218 166
Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells 2007 145 0
Henoch Schönlein purpura following etanercept treatment of rheumatoid arthritis 2006 187 0
The new IL-1 family member IL-1F8 stimulates production of inflammatory mediators by synovial fibroblasts and articular chondrocytes 2006 204 87
Leukocyte migration to rheumatoid joints: Enzymes take over 2006 181 1
Intracellular interleukin-1 receptor antagonist type 1 antagonizes the stimulatory effect of interleukin-1 alpha precursor on cell motility 2005 142 156
Total hip prosthetic joint infection due to Veillonella species 2004 218 0
Delayed resolution of acute inflammation during zymosan-induced arthritis in leptin-deficient mice 2004 103 39
21018 6468